Avelumab Plus 2nd-generation ADT in African American Subjects With mCRPC
Clinical trial NCT03770455 · TERMINATED
Trial details
- NCT number
- NCT03770455
- Sponsor
- Jodi Layton, MD
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-25
- Primary completion
- 2020-12-17
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.